ACHC — Acadia Healthcare Income Statement
0.000.00%
Last trade - 00:00
- $7.10bn
- $8.97bn
- $2.93bn
- 65
- 47
- 85
- 71
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,008 | 2,090 | 2,314 | 2,610 | 2,929 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,743 | 1,781 | 1,962 | 2,166 | 2,882 |
Operating Profit | 266 | 309 | 353 | 444 | 47 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 78.4 | 184 | 276 | 374 | -25.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 53.3 | 143 | 208 | 280 | -15.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 109 | -672 | 191 | 273 | -21.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 109 | -672 | 191 | 273 | -21.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.968 | 1.81 | 2.6 | 3 | 2.98 |